Title:
上皮性卵巣がんおよびその他のがんに対する免疫療法において使用するための新規ペプチドおよびペプチドの組み合わせ
Document Type and Number:
Japanese Patent JP7074367
Kind Code:
B2
Abstract:
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
Inventors:
Schuster, Heiko
Pepel, Janet
Wagner, filip
Rammensee, Hans-Georg
Pepel, Janet
Wagner, filip
Rammensee, Hans-Georg
Application Number:
JP2020052558A
Publication Date:
May 24, 2022
Filing Date:
March 24, 2020
Export Citation:
Assignee:
Immatics Biotechnology Gem Beher
International Classes:
C07K7/06; A61K31/713; A61K35/17; A61K38/08; A61K38/16; A61K39/395; A61P35/00; A61P35/02; C07K14/47; C07K14/725; C07K16/18; C07K19/00; C12N5/0783; C12N5/0784; C12N5/10; C12N15/115; C12N15/12; C12N15/62; C12N15/63; C12P21/02
Domestic Patent References:
| JP2013521789A | ||||
| JP2008500033A |
Foreign References:
| WO2015018805A1 |
Attorney, Agent or Firm:
Takashi Shoji
Previous Patent: Iron oxide for orange pigments and its manufacturing method
Next Patent: Fluxgate magnetic field sensor
Next Patent: Fluxgate magnetic field sensor